Related Experiment Video

Updated: Jul 2, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Vascular targeted therapies in oncology

Dietmar W Siemann1, Michael R Horsman

  • 1Department of Radiation Oncology, University of Florida, 2000 SW Archer Road, Gainesville, FL, USA. siemadw@ufl.edu

Cell and Tissue Research
|August 30, 2008
PubMed

Insights

Targeting tumor neovascularization with vascular disrupting therapies offers a novel strategy to enhance cancer treatment. These therapies aim to shut down tumor blood vessels, leading to cell death from oxygen and nutrient deprivation.

Area of Science:

  • Oncology
  • Vascular Biology

Background:

  • Neovascularization is crucial for tumor survival, progression, and metastasis.
  • Tumor angiogenesis contributes significantly to treatment failure.
  • Targeting tumor vasculature presents therapeutic opportunities and enhances conventional treatments.

Purpose of the Study:

  • To review vascular disrupting therapies (VDTs) as a strategy targeting tumor neovasculature.
  • To discuss the mechanism of VDTs in causing tumor vascular shutdown.

Main Methods:

  • Review of existing literature on vascular disrupting therapies.
  • Analysis of the physiological impact of vascular disruption on tumor growth.

Main Results:

  • VDTs aim to destroy established tumor neovasculature.
  • Rapid shutdown of tumor vascular function is the primary goal.
  • Arrested blood flow leads to tumor cell death via deprivation and waste accumulation.

Conclusions:

  • Vascular disrupting therapies represent a promising approach in oncology.
  • Targeting tumor vasculature can enhance the efficacy of existing cancer treatments.
  • VDTs offer a unique strategy to combat tumor survival and progression.

More Related Videos

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.